# Clinical Case Report

Overview

The unknown Oxford Nanopore sequencing dataset was analyzed to identify the bacterial species, evaluate the quality of the genome assembly, determine the sequence type, and investigate antimicrobial resistance, plasmids, and virulence-related features. The workflow included genome assembly, assembly quality assessment, species identification, sequence typing, antimicrobial resistance analysis, plasmid characterization, and virulence profiling. Together, these analyses provided a comprehensive characterization of the isolate and its potential clinical significance.

Read Quality Assessment

Oxford Nanopore sequencing generated 260,294 reads containing 576,590,333 bases. The average read length was 2,215 bp, with an N50 of 15,932 bp. The average quality score was 20.25, and the GC content was 55.85%. These quality metrics suggested that the sequencing data were suitable for downstream genome assembly and genomic analyses (Kolmogorov et al., 2019).

Genome Assembly

The sequencing reads were assembled using Flye, producing 12 contigs with a total assembly size of 5,896,334 bp. The largest contig was 5,306,074 bp, resulting in an assembly N50 of 5,306,074 bp. Assembly quality was evaluated with QUAST, which reported an L50 of 1 and no ambiguous bases (Ns), suggesting a high-quality genome assembly suitable for downstream analyses (Gurevich et al., 2013).

Species Identification

Species identification was performed using the NCBI BLAST nucleotide database. Because the assembled genome was too large to be submitted through the BLAST web interface as a single sequence, the largest contig (contig_4) was extracted, and the first 100,000 bp were used for the BLAST search. The isolate was identified as Klebsiella pneumoniae with 100% sequence identity and 100% query coverage. This identification was consistent with the results obtained from Kleborate, supporting the accuracy of the species assignment.

Sequence Typing

MLST analysis assigned the isolate to Sequence Type 258 (ST258). This sequence type is commonly associated with multidrug-resistant clinical isolates of Klebsiella pneumoniae and supported the species identification obtained through BLAST.

Antimicrobial Resistance Analysis

AMRFinderPlus identified several antimicrobial resistance genes in the assembled genome. These included the carbapenemase gene blaKPC-3, together with blaTEM-1, blaOXA-9, and blaSHV-11. Additional genes associated with resistance to aminoglycosides, sulfonamides, phenicols, fosfomycin, quinolones, and disinfectants were also detected. The presence of multiple resistance genes indicated that the isolate carries several antimicrobial resistance mechanisms.

Plasmid Analysis

PlasmidFinder detected multiple plasmid replicons, including IncI2, IncFIB(K), IncFII(K), IncFII(Yp), and IncR. AMRFinderPlus identified the blaKPC-3 gene on contig_15, and MOB-suite classified this contig as a plasmid. Together with the IncI2 replicon detected by PlasmidFinder, these findings indicate that blaKPC-3 is located on an IncI2 plasmid rather than on the chromosome. Because plasmids can be transferred between bacteria through horizontal gene transfer, the plasmid location of blaKPC-3 suggests that this carbapenem resistance gene has the potential to spread to other bacteria (Carattoli et al., 2014).

Virulence Analysis

Kleborate identified the isolate as Klebsiella pneumoniae ST258 with a virulence score of 0, indicating that no major hypervirulence-associated genes were detected. The isolate carried the KL107 (wzi154) capsule type and the O13 O-antigen type. Kleborate also reported a resistance score of 2, indicating resistance across 10 antimicrobial classes. These findings suggest that the isolate belongs to a multidrug-resistant lineage rather than a hypervirulent one (Pitout & Nordmann, 2015).

Interpretation

The combined results identified the unknown isolate as Klebsiella pneumoniae ST258, a sequence type commonly associated with multidrug-resistant hospital infections (Wyres & Holt, 2018). AMRFinderPlus detected multiple antimicrobial resistance genes, including blaKPC-3, which encodes a carbapenemase associated with resistance to carbapenem antibiotics (Munoz-Price et al., 2013), together with several additional genes associated with resistance to other antimicrobial classes. These findings suggest that the isolate carries multiple antimicrobial resistance mechanisms, although phenotypic antimicrobial susceptibility testing is required to confirm the predicted resistance profile (Feldgarden et al., 2021).

PlasmidFinder and MOB-suite showed that blaKPC-3 is located on an IncI2 plasmid. Because plasmids can facilitate the transfer of resistance genes between bacteria, plasmid-associated carbapenem resistance is an important concern in clinical settings (Carattoli et al., 2014).

Although no major hypervirulence-associated genes were detected, the isolate remains clinically significant because it belongs to the high-risk ST258 lineage and carries numerous antimicrobial resistance genes. This is consistent with previous studies showing that ST258 isolates are generally multidrug resistant rather than hypervirulent (Wyres & Holt, 2018).

Overall, the combined use of multiple bioinformatics tools made it possible to identify the bacterial species and comprehensively characterize its genome, antimicrobial resistance genes, plasmids, sequence type, and virulence-related features.

Conclusion

This analysis successfully characterized an unknown bacterial isolate using an Oxford Nanopore whole-genome sequencing workflow. The isolate was identified as Klebsiella pneumoniae ST258 and was found to carry multiple antimicrobial resistance genes, including the carbapenemase gene blaKPC-3. Plasmid analysis indicated that blaKPC-3 is located on an IncI2 plasmid, suggesting the potential for horizontal gene transfer. Overall, this workflow demonstrates how whole-genome sequencing and bioinformatics tools can be used to identify bacterial pathogens and investigate antimicrobial resistance, plasmids, and other clinically important genomic features.